FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Court Orders FDA Reconsideration of Brixadi Application

The DC federal court says FDA should reconsider its exclusivity decision for Indiviors Sublocade that blocked Braeburns Brixadi from approval.

Human Drugs

CGMP Deviations in High Chemical Inspection

FDA warns High Chemical about CGMP deviations in its production of active pharmaceutical ingredients.

Human Drugs

Warning Issued to CBD Maker Over Illegal Claimsֺ

FDA issues a Warning Letter to Curaleaf (Wakefield, MA) for illegally selling unapproved products containing cannabidiol online with unsubstantiated p...

Federal Register

Guide on Combo Product Postmarketing Reporting

Federal Register notice: FDA makes available a final guidance entitled Postmarketing Safety Reporting for Combination Products Guidance for Industry a...

Medical Devices

Medtronic Seeks Non-Adjunctive Label for Insulin Sensor

Medtronic files a PMA for non-adjunctive labeling for its Guardian Sensor 3, which is part of the MiniMed 670G insulin delivery system.

Human Drugs

PhRMA Lobbying Influencing Administration: Analysis

Restore Public Trust says the drug industry is setting new records for lobbying spending in an effort to influence the Trump administration and Congre...

FDA General

Latest FDA Warning Letters

FDA releases its latest batch of Warning Letters that includes High Chemical, Indoco Remedies and Stratus BioSystems.

Human Drugs

Bayer Recalls 2 Lots of Kogenate Vials

FDA says Bayer is recalling two lots of Kogenate FS because some vials contained its Jivi antihemophilic factor rather than Kogenate.

Biologics

FDA Approves Pfizers Rituxan Biosimilar

FDA approves a Pfizer BLA for Ruxience (rituximab-pvvr), a biosimilar to Biogens Rituxan for three indications.

FDA General

Final Guide on Combo Product Safety Reporting

FDA posts a final guidance on Postmarketing Safety Reporting for Combination Products.